Ribavirin attenuates carcinogenesis by downregulating IL-6 and IL-8 in vitro in human lung adenocarcinoma

De Rubis, G Paudel, KR Yeung, S Agarwal, V Hansbro, PM Oliver, BGG Dua, K

Permalink

Closed Access

	Filename	Description	Size
	Ribavarin_IL-6 and IL-8_1-s2.0-S0344033823007392-main.pdf	Published version	466.78 kB	Adobe PDF	View/Open

Copyright Clearance Process

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	De Rubis, G
dc.contributor.author	Paudel, KR
dc.contributor.author	Yeung, S
dc.contributor.author	Agarwal, V
dc.contributor.author	Hansbro, PM
dc.contributor.author	Oliver, BGG
dc.contributor.author	Dua, K https://orcid.org/0000-0002-7507-1159
dc.date.accessioned	2023-12-15T02:49:57Z
dc.date.available	2023-12-15T02:49:57Z
dc.date.issued	2023-12
dc.identifier.citation	Pathology - Research and Practice, 2023, pp. 155038-155038
dc.identifier.issn	0344-0338
dc.identifier.uri	http://hdl.handle.net/10453/173840
dc.language	en
dc.publisher	Elsevier BV
dc.relation.ispartof	Pathology - Research and Practice
dc.relation.isbasedon	10.1016/j.prp.2023.155038
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	1103 Clinical Sciences
dc.subject.classification	Pathology
dc.subject.classification	3202 Clinical sciences
dc.subject.classification	3211 Oncology and carcinogenesis
dc.title	Ribavirin attenuates carcinogenesis by downregulating IL-6 and IL-8 in vitro in human lung adenocarcinoma
dc.type	Journal Article
utslib.for	1103 Clinical Sciences
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Science
pubs.organisational-group	/University of Technology Sydney/Strength - CFI - Centre for Inflammation
utslib.copyright.status	closed_access	*
dc.date.updated	2023-12-15T02:49:56Z
pubs.publication-status	Published

Please use this identifier to cite or link to this item: